Integra Diagnosticsp. z o.o.
Retail sale of medical and orthopaedic goods in specialised stores
Overview
Integra Diagnostic supplies diagnostic tests and simple devices for self-use, as well as products for pharmacies. Its range includes urine and blood tests, tests for SARS-CoV-2, Lyme disease, urinary tract infections and occult blood in stool, along with disposable breathalyzers.
Financials
Revenue history (in k)
Financial insight
- companies.financials.estonianCitCertain
Filing timeliness
1 of 3 financial statements was filed late (for 2023, 4 days late).
- 2025filed
- 202411/07/2025
- 202319/07/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Public procurement
Integra Diagnostic is the contractor in 2 public sector contracts, worth USD 82.43 in total. They were signed with 2 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Sep 29, 2026 | Purchase of drug tests for training purposes for Sąd Rejonowy w Gorzowie Wielkopolskim. | $18.90 | SĄD Rejonowy w Gorzowie Wlkp. | |
| Sep 24, 2026 | PINK highly sensitive cassette pregnancy test; | $63.53 | Uniwersytet Warszawski |
Trademarks
Integra Diagnostic holds 2 active trademarks registered with the Polish Patent Office. 2 applications are pending. The first mark was filed in 2021.
| Mark | Protected until | |
|---|---|---|
| IN INTEGRA DIAGNOSTIC | Oct 14, 2031 | |
| samsiezbadaj pl | May 21, 2031 | |
| BS BIOSAFE | – | |
| INTEGRA DIAGNOSTIC MED. | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by a member of the management board; in the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dorota Julia Zdziebkowskaage 62 | 490 | $6,618.04 | 49% |
Katarzyna Anna Zdziebkowskaage 61 | 490 | $6,618.04 | 49% |
Others | 20 | $270.12 | 2% |
Dorota Julia Zdziebkowska and Katarzyna Anna Zdziebkowska hold a combined 98% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-07-02.
05 1750 1019 0000 0000 3371 5501- 46 1750 1019 0000 0000 3368 9737
- 90 1750 1019 0000 0000 3368 9721
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Optidentsp. z o.o. | $25,073,929.05 | optident.pl | ||
| Transcom Internationalsp. z o.o. | $3,657,709.07 | transcom.com.pl | ||
| Integra Medicalsp. z o.o. | $3,348,989.87 | integramedical.eu | ||
| Medical Marketsp. z o.o. | $3,352,570.35 | medical-market.pl | ||
| Sigmedsp. z o.o. | $3,078,500.37 | sigmed.eu | ||
| Biogenetsp. z o.o. | $2,831,672.67 | biogenet.pl | ||
| Sonologisticsp. z o.o. + limited partnership | $2,824,443.10 | sonologistic.pl | ||
| Syngen Biotechsp. z o.o. | $2,134,012.94 | syngen.pl | ||
| Solt Zdrowiesp. z o.o. + limited partnership | $1,777,109.57 | soltzdrowie.pl | ||
| Xdentalsp. z o.o. | $1,472,761.07 | xdental.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-10-10 | Address change (Ul. Polska 114, 60-401, Poznań → Ul. Człuchowska 6, 60-434, Poznań) | |
| 2023-01-02 | Entered in the register |
FAQ
Last updated: 2026-04-18